Two previously documented cases treated with the systemic VEGF inhibitor SU5416 have reported a reduction in macular oedema and an improvement in visual acuity whilst undergoing treatment but a relapse following treatment withdrawal [5,6]. The gene discussed is VEGFA; the disease is macular retinal edema.